Plasfer unveils a redesigned website — clearer, faster and built around its two verticals, with regenerative medicine now front and centre alongside the oncology pipeline.
Plasfer today launched its redesigned website — a clearer, faster window onto the company’s Platelet Transfer Technology (PTT) platform and its pipeline.
What’s new
The new site is built around Plasfer’s two verticals — regenerative medicine and oncology — with the near-term regenerative programme, PLA-REGEN, now given a place of its own alongside the oncology work.
Visitors will find a streamlined platform overview, a clearer pipeline snapshot, and dedicated paths for the audiences that matter most to us: development partners, investors, and the scientific community.
Why it matters
As Plasfer advances both its regenerative and oncology programmes, the website is where partners and investors get their first, clearest picture of what the platform can do. The redesign reflects that — less text, more clarity, and a structure that mirrors how the company is building value.
“Our science had outgrown our old site. This is a clearer statement of what we do and where we’re going.” — Marco Malvestiti, CEO
For partnering or investment enquiries, please contact us.